• Home
  • About medac
  • Information for patients
  • Healthcare professionals
  • Products
  • Career opportunities
  • Media
  • medac News

    medac News


    Read more

    Press Release

    medac GmbH: New Management structure

    Read more

    A reliable diagnosis with the new cPass test by medac GmbH

    Is it possible that I’m already immune to COVID-19?

    In the time of lockdowns and vaccination chaos, a new diagnostic procedure finally provides...

    Read more

    medac statement on Coronavirus (SARS-CoV-2)

    At this moment in time, and after consultation of the competent authorities, we do not foresee any interruptions in production and therefore no supply...

    Read more

    Trecondi® - the new original from medac

    After 20 years of intensive research and development activity in the field of haematology and oncology, medac received EU-wide marketing authorisation...

    Read more

    NEW in the Haematology Portfolio: Carmustin Obvius

    With the launch of Carmustin Obvius in Germany, the Haematology Portfolio has been augmented by an additional substance.

    The active substance...

    Read more

    Delivery failure urokinase

    Urokinase medac is not available at the moment. At present, work is underway on a new production of the drug in order to provide patients with...

    Read more

    medac at the EBMT 2019

    Innovative conditioning therapy for MDS and AML

    Nach oben